Cizzle Biotechnology Share Price, News & Analysis (LON:CIZ) GBX 2.38 +0.01 (+0.42%) (As of 02:19 PM ET) Add Share Share Today's Range 2.36▼ 2.5650-Day Range 1.71▼ 2.5052-Week Range 1.36▼ 4.84Volume2.08 million shsAverage Volume3.51 million shsMarket Capitalization£8.68 millionAssets Under Management£48.98 millionDividend Yield3.31%Net Expense Ratio0.46% Stock AnalysisStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings About Cizzle Biotechnology (LON:CIZ)Cizzle Biotechnology Holdings Plc engages in development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.Read More CIZ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CIZ ETF News HeadlinesAugust 15, 2023 | lse.co.ukMurphy Canyon to hold meeting on planned buy of interest in AZD1656August 10, 2023 | lse.co.ukTRADING UPDATES: Aterian granted 10 exploration licences in MoroccoDecember 6, 2023 | Financial Alphas (Ad)Lithium Discovery So BIG You Can't Miss it, Even From SpaceWith the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!July 18, 2023 | bizjournals.comPhiladelphia Biotech NewsJuly 16, 2023 | investing.comCizzle Biotechnology Holdings PLC (CIZ)June 12, 2023 | lse.co.ukCizzle subscription raises GBP350,000 to fund development pipelineJune 12, 2023 | marketwatch.comCizzle Biotechnology Raises GBP350,000 via SubscriptionMay 23, 2023 | finance.yahoo.comInstitutional investors own a significant stake of 50% in Cizzle Biotechnology Holdings Plc (LON:CIZ)December 6, 2023 | Financial Alphas (Ad)Lithium Discovery So BIG You Can't Miss it, Even From SpaceWith the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!April 22, 2023 | investing.comEFA ETF Volatility (VXEFA)See More Headlines Receive CIZ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cizzle Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerVictory Capital Management Fund NameVictoryShares Developed Enhanced Volatility Wtd ETF Tax ClassificationRegulated Investment Company Stock ExchangeLONCurrent SymbolLON:CIZ Inception Date9/30/2014 Fund ManagerMannik Dhillon, Stephen Hammers Webwww.cizzlebiotechnology.com PhoneN/AFund Focus Asset ClassEquity BenchmarkNasdaq Victory?International 500 Long/Cash Volatility Weighted Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionGlobal Ex-U.S. Number of Holdings505 Fund Statistics Assets Under Management$48.98 million Average Daily Volume$9,243.20 Discount/Premium0.17% Administrator, Advisor and Custodian AdministratorVictory Capital Management Inc. AdvisorVictory Capital Management Inc. CustodianCitibank, N.A. DistributorForeside Fund Services, LLC Transfer AgentCitibank, N.A. TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest15,600 shs Miscellaneous Outstanding Shares363,840,000Beta0.13 Creation Unit50,000 Creation Fee$4,500.00 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Cizzle Biotechnology ExpensesTypeCIZLarge Cap ETFsEquity ETFsLON ETFsAll ETFsManagement Fee0.40%0.56%0.53%0.45%0.51%Other Expenses0.25%0.30%0.53%0.25%0.57%Total Expense0.66%0.63%0.69%0.54%0.69%Fee Waiver-0.20%-0.20%-0.54%-0.20%-0.58%Net Expense0.46%0.60%0.59%0.47%0.57% Cizzle Biotechnology (CIZ) Holdings & ExposureTop 10 CIZ HoldingsFederated Hermes Treasury Obl ISHolding Weight: 75.19%Mini Msci Eafe Fut Dec23Holding Weight: 0.47%Murata Manufacturing Co LtdHolding Weight: 0.15%Futures Collateral - CashHolding Weight: 0.13%Honda Motor Co LtdHolding Weight: 0.13%Keyence CorpHolding Weight: 0.12%SoftBank CorpHolding Weight: 0.12%BCE(NYSE:BCE)Holding Weight: 0.09%(GWO)(NYSEARCA:GWO)Holding Weight: 0.09%Koninklijke KPN NVHolding Weight: 0.09%CIZ Sector ExposureCIZ Industry ExposureFull Holdings Details Key ExecutivesMr. Allan John Syms (Age 66)Executive Chairman Prof. Dawn Coverley (Age 57)Founder, Chief Scientific Officer & Non-Executive Director Mr. Nigel R. Lee (Age 61)Finance Director & Executive Director Mr. Morgan WilliamsHead of Commercialisation for Yorkshire Cancer Research and Board Observer CIZ ETF - Frequently Asked Questions How have CIZ shares performed in 2023? Cizzle Biotechnology's stock was trading at GBX 1.45 at the start of the year. Since then, CIZ stock has increased by 64.5% and is now trading at GBX 2.39. View the best growth stocks for 2023 here. How often does Cizzle Biotechnology pay dividends? What is the dividend yield for Cizzle Biotechnology? Cizzle Biotechnology announced a monthly dividend on Tuesday, May 9th. Stockholders of record on Thursday, May 11th will be given a dividend of GBX 0.09 per share on Friday, May 12th. This represents a $1.08 dividend on an annualized basis and a yield of 45.28%. The ex-dividend date of this dividend is Wednesday, May 10th. Read our dividend analysis for CIZ. What does CIZ invest in? Cizzle Biotechnology is a equity fund issued by Victory Capital Management. CIZ focuses on large cap investments and follows the Nasdaq Victory?International 500 Long/Cash Volatility Weighted Index. The fund's investments total to approximately $48.98 million assets under management. What stocks does Cizzle Biotechnology hold? CIZ invests in 505 holdings. Some of the stocks in their portfolio include BCE (BCE), (GWO) (GWO), Metro, Inc. (TSE) (MRU), WisdomTree International LargeCap Dividend Fund (DOL), Fortis (FTS), Hyatt Hotels (H), Powered Brands (POW), Royal Bank of Canada (RY), Sun Life Financial (SLF) and Loews (L). What is the management fee for Cizzle Biotechnology? Cizzle Biotechnology's management fee is 0.40% and has other expenses of 0.25%. However, CIZ has a fee waiver of -0.20% to reimburse the expenses. The net expense ratio for CIZ is 0.46%. How do I buy shares of Cizzle Biotechnology? Shares of CIZ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:CIZ) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cizzle Biotechnology Holdings Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.